Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Chris Froome: UCI 'right' to ask questions over failed test result

"I have the utmost confidence that Chris followed the medical guidance in managing his asthma symptoms, staying within the permissible dose for Salbutamol.

"As a matter of principle, and whilst not required by the World Anti-Doping Code, the UCI systematically reports potential anti-doping rule violations via its website when a Mandatory Provisional Suspension applies.

"Pursuant to Article 7.9.1. of the UCI Anti-Doping Rules, the presence of a Specified Substance such as Salbutamol in a sample does not result in the imposition of such mandatory provisional suspension against the rider."

Last week former UCI chief Brian Cookson said Team Sky should have its reputation "reinstated" following unproven doping allegations and questions over its use of therapeutic use exemptions (TUEs) - permission to use otherwise-banned substances when there is a proven medical need.

Froome was named in leaked medical records by the Russian hackers Fancy Bears as one of the athletes to use TUEs during competition.


  • Chris Froome could be stripped of Vuelta a Espana title after abnormal urine
  • Tour de France champion Chris Froome failed urine test at VueltaMetro
  • Tour de France star returns 'adverse analytical finding' to asthma medication ...The Advertiser
  • Tour de France winner Chris Froome returns abnormal doping test at VueltaUSA TODAY
  • Chris Froome insists UCI right to ask questions as abnormal drugs test result
  • Chris Froome 'could lose Vuelta title' as UCI probes drugs test
  • Chris Froome failed urine test at VueltaSky News
  • Froome says asthma drug behind 'adverse finding'The Star Online
  • Chris Froome could face 12-month ban from cycling after failed drugs test at ...Daily Mail

This post first appeared on The 5th News, please read the originial post: here

Share the post

Chris Froome: UCI 'right' to ask questions over failed test result


Subscribe to The 5th News

Get updates delivered right to your inbox!

Thank you for your subscription